Aprime SA
Dissolution volontaire – liquidationAprime reported revenue of €8.60m for the 2006 financial year (annual accounts filed with the NBB on 29 Dec 2006).
The score of Aprime shows with a free account.
See the score- Summary? / 5
- Balance sheet strength
- Liquidity
- Repayment capacity
- Profitability
- Trajectory
- Compliance and register
- Position in its sectorvs peers
- Supplier creditat 30 d
- Borrowing capacityborrowable
- Valuationcentral
Visible once signed in: create your account, the 14-day Pro trial is free.
Key figures 2006
Accounts of the company itself (not consolidated).
Deterministic calculation on the filed accounts, no AI. Dispute the score or report an error
Aprime's annual accounts
Filed annual accounts
- Year ended 31 Mar 2009filed on 04 Dec 2009
- Year ended 31 Mar 2008filed on 17 Mar 2009
- Year ended 31 Mar 2007filed on 31 Mar 2008
- Year ended 31 Mar 2006filed on 29 Dec 2006
- Year ended 30 Jun 2005filed on 02 Feb 2006
Aprime's financial analysis
- Solvency39.0%sector median: 43.9%
- Current ratio
- Net margin
- ROE
- Financial debt / EBITDA
- Interest coverage
- Days sales outstanding (DSO)
Management and control of Aprime
Aprime's publications in the Belgian Gazette
Company number, VAT number and registered office
- Company number (CBE)
- 0460.932.617
- VAT number
- BE0460932617
- Peppol
- Not found on Peppol as of 10 Nov 2026 · Check
- Legal form
- SA
- Incorporated
- 27 Jun 1997
- Registered office
- 1410 Waterloo
- Latest accounts
- 2006 · filed on 04 Dec 2009
- Activity
- Wholesale of pharmaceutical and medical goods (NACE 4646001)
Aprime (SA) has been based in Waterloo since 1997, active in: wholesale of pharmaceutical and medical goods. For 2006, it reports revenue of €8.60m, a net profit of — and equity of €2.72m. Its solvency stands at 39.0%, below the median of its sector (43.9%).
Guide: Reading Belgian SME accounts: the five figures that count →
Companies similar to Aprime
Same activity (NACE code), registered office in the same province, closest balance-sheet size.
- Celyntra Therapeutics Wholesale of pharmaceutical and medical goods Mont-Saint-Guibert · balance sheet €8.20m
- EKI'P Dental Wholesale of pharmaceutical and medical goods Wavre · balance sheet €5.78m
- Interscience Belgium Wholesale of pharmaceutical and medical goods Ottignies-Louvain-la-Neuve · balance sheet €5.67m
- Arkopharma Belux Wholesale of pharmaceutical and medical goods Wavre · balance sheet €5.33m
- Bausch & Lomb Pharma Wholesale of pharmaceutical and medical goods Wavre · balance sheet €9.17m
- APEX Wholesale of pharmaceutical and medical goods Braine-l'Alleud · balance sheet €5.25m
- Cosmex Wholesale of pharmaceutical and medical goods Tubize · balance sheet €5.20m
- Dental Addict Wholesale of pharmaceutical and medical goods Braine-l'Alleud · balance sheet €5.15m
Frequently asked questions about Aprime
What is the revenue of Aprime?
According to the 2006 annual accounts filed with the NBB, the revenue of Aprime amounts to 8,603,000 €.
What is the VAT number of Aprime?
In Belgium, the VAT number is the company number prefixed with BE: BE0460932617 for Aprime, if the company is VAT-registered. Its company number (CBE) is 0460.932.617.
Where is the registered office of Aprime?
According to the CBE register, the registered office of Aprime is in 1410 Waterloo.
What is the equity of Aprime?
At the close of the 2006 financial year, the equity of Aprime amounts to 2,723,000 €, a solvency of 39.0% of total assets.
Who manages Aprime?
The register lists 9 active mandates at Aprime. Names and roles are in the full file, with the deeds published in the Belgian Gazette.
The full file of Aprime
Directors and mandates, ownership network, Gazette deeds, ten years of accounts and ratios, Excel export, and Idonis's analysis in one question.
Open the full file →